David J. Madar

1.2k total citations
20 papers, 639 citations indexed

About

David J. Madar is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, David J. Madar has authored 20 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in David J. Madar's work include Diabetes Treatment and Management (3 papers), Traditional and Medicinal Uses of Annonaceae (3 papers) and Cyclization and Aryne Chemistry (2 papers). David J. Madar is often cited by papers focused on Diabetes Treatment and Management (3 papers), Traditional and Medicinal Uses of Annonaceae (3 papers) and Cyclization and Aryne Chemistry (2 papers). David J. Madar collaborates with scholars based in United States and United Kingdom. David J. Madar's co-authors include Scott B. Cohen, Mark E. Fraley, Norma J. Tom, Andrew G. Myers, Ravi Kurukulasuriya, J. T. Link, William Roush, Zhili Pei, Jon E. Rohde and Andrew J. Souers and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Biochemistry.

In The Last Decade

David J. Madar

18 papers receiving 615 citations

Peers

David J. Madar
Marlys Hammond United States
Seung Kyu Kang South Korea
Bernard Hulin United States
Conrad Santini United States
Ralf Plate Netherlands
David J. St. Jean United States
Steven M. Sparks United States
Thomas J. Rayl United States
Dominique Lesuisse France
Anthony Mastracchio United States
Marlys Hammond United States
David J. Madar
Citations per year, relative to David J. Madar David J. Madar (= 1×) peers Marlys Hammond

Countries citing papers authored by David J. Madar

Since Specialization
Citations

This map shows the geographic impact of David J. Madar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Madar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Madar more than expected).

Fields of papers citing papers by David J. Madar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Madar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Madar. The network helps show where David J. Madar may publish in the future.

Co-authorship network of co-authors of David J. Madar

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Madar. A scholar is included among the top collaborators of David J. Madar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Madar. David J. Madar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bruncko, Milan, Stephen K. Tahir, Xiaohong Song, et al.. (2010). N-Aryl-benzimidazolones as novel small molecule HSP90 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(24). 7503–7506. 33 indexed citations
2.
Madar, David J., Amar Patel, & Watson J. Lees. (2009). Comparison of the oxidative folding of lysozyme at a high protein concentration using aromatic thiols versus glutathione. Journal of Biotechnology. 142(3-4). 214–219. 15 indexed citations
3.
Backes, Bradley J., Kenton L. Longenecker, Gregory L. Hamilton, et al.. (2007). Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit. Bioorganic & Medicinal Chemistry Letters. 17(7). 2005–2012. 31 indexed citations
4.
Yeh, Vince S. C., Ravi Kurukulasuriya, David J. Madar, et al.. (2006). Synthesis and structural activity relationship of 11β-HSD1 inhibitors with novel adamantane replacements. Bioorganic & Medicinal Chemistry Letters. 16(20). 5408–5413. 23 indexed citations
5.
Longenecker, Kenton L., Kent D. Stewart, David J. Madar, et al.. (2006). Crystal Structures of DPP-IV (CD26) from Rat Kidney Exhibit Flexible Accommodation of Peptidase-Selective Inhibitors. Biochemistry. 45(24). 7474–7482. 32 indexed citations
6.
Shoemaker, Alex R., Michael J. Mitten, Jessica Adickes, et al.. (2006). The Bcl-2 Family Inhibitor ABT-263 Shows Significant but Reversible Thrombocytopenia in Mice.. Blood. 108(11). 1107–1107. 5 indexed citations
7.
Kurukulasuriya, Ravi, J. T. Link, David J. Madar, et al.. (2003). Potential Drug Targets and Progress Towards Pharmacologic Inhibition of Hepatic Glucose Production. Current Medicinal Chemistry. 10(2). 123–153. 75 indexed citations
8.
Kurukulasuriya, Ravi, J. T. Link, David J. Madar, et al.. (2003). Prospects for Pharmacologic Inhibition of Hepatic Glucose Production. Current Medicinal Chemistry. 10(2). 99–121. 46 indexed citations
9.
10.
11.
Madar, David J., Hana Kopecka, Daisy Pireh, et al.. (2001). Synthesis of N-arylated oxazolidinones via a palladium catalyzed cross coupling reaction. Application to the synthesis of the antibacterial agent Dup-721. Tetrahedron Letters. 42(22). 3681–3684. 37 indexed citations
12.
13.
Trevillyan, James M., X. Grace Chiou, Stephen J. Ballaron, et al.. (1999). Inhibition of p56lckTyrosine Kinase by Isothiazolones. Archives of Biochemistry and Biophysics. 364(1). 19–29. 28 indexed citations
14.
Roush, William, Donald S. Coffey, & David J. Madar. (1997). Total Synthesis of (+)-Damavaricin D. Journal of the American Chemical Society. 119(46). 11331–11332. 36 indexed citations
15.
Myers, Andrew G., Norma J. Tom, Mark E. Fraley, Scott B. Cohen, & David J. Madar. (1997). A Convergent Synthetic Route to (+)-Dynemicin A and Analogs of Wide Structural Variability. Journal of the American Chemical Society. 119(26). 6072–6094. 162 indexed citations
16.
Coffey, Donald S., et al.. (1996). Studies on the Synthesis of the Streptovaricins: Total Synthesis of 24,27-Dimethyl Dihydrodamavaricin D. Journal of the Brazilian Chemical Society. 7(5). 327–334. 6 indexed citations
17.
Myers, Andrew G., Mark E. Fraley, Norma J. Tom, Scott B. Cohen, & David J. Madar. (1995). Synthesis of (+)-dynemicin A and analogs of wide structural variability: establishment of the absolute configuration of natural dynemicin A. Chemistry & Biology. 2(1). 33–43. 70 indexed citations
18.
Myers, Andrew G., Scott B. Cohen, Norma J. Tom, David J. Madar, & Mark E. Fraley. (1995). Insights into the Mechanism of DNA Cleavage by Dynemicin A as Revealed by DNA-Binding and -Cleavage Studies of Synthetic Analogs. Journal of the American Chemical Society. 117(28). 7574–7575. 29 indexed citations
19.
Roush, William & David J. Madar. (1993). Towards the synthesis of streptovaricin D: Synthesis of fully elaborated aromatic precursors and coupling with ansa chain fragments. Tetrahedron Letters. 34(10). 1553–1556. 5 indexed citations
20.
Siegel, Arthur J., et al.. (1982). ELEVATED SKELETAL MUSCLE CREATINE KINASE MB ISOENZYME LEVELS IN MARATHON RUNNERS. Medicine & Science in Sports & Exercise. 14(2). 171–171. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marlys Hammond Breakdown of academic impact, for papers by Seung Kyu Kang Breakdown of academic impact, for papers by Bernard Hulin Breakdown of academic impact, for papers by Conrad Santini Breakdown of academic impact, for papers by Ralf Plate Breakdown of academic impact, for papers by David J. St. Jean Breakdown of academic impact, for papers by Steven M. Sparks Breakdown of academic impact, for papers by Thomas J. Rayl Breakdown of academic impact, for papers by Dominique Lesuisse Breakdown of academic impact, for papers by Anthony Mastracchio
Rankless by CCL
2026